← Leaderboards
John D Imig
Vanderbilt University
$12,270,295
Attributed
$12,270,295
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $944.6K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,270,295 · 8
By mechanism
R01$7,981,247 · 3
P01$3,814,647 · 3
T32$374,401 · 1
R41$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Jorge H Capdevila$6,372,994
- Nancy Brown$1,497,008
- Steven C Hebert$6,419,909
- Nancy Joan Brown$32,445,188
- Richard M Breyer$8,994,550
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyKidney DiseasesFunctional DisorderHypertensionMicrocirculationBlood Pressure RegulationAcidsInjuryEicosanoidsBlood PressureEpoxide HydrolaseEndotheliumCytochrome P450Eicosanoid MetabolismRodent ModelAntihypertensive AgentsInflammationMetabolic SyndromeCardiovascular SystemAttenuatedBlood VesselsHemodynamicsDiabetes MellitusOrgan
Grant awards (44)
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation$514,673
R01 · FY2025 · DK · contact PI
CTSA Postdoctoral T32 at University of Arkansas for Medical Sciences$183,806
T32 · FY2025 · TR · contact PI
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation$494,087
R01 · FY2024 · DK · contact PI
CTSA Postdoctoral T32 at University of Arkansas for Medical Sciences$190,595
T32 · FY2024 · TR · contact PI
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation$514,673
R01 · FY2023 · DK · contact PI
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation$329,654
R01 · FY2022 · DK · contact PI
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation$175,856
R01 · FY2022 · DK · contact PI
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation$562,842
R01 · FY2021 · DK · contact PI
Eicosanoid-based Therapy for Diabetes$474,430
R01 · FY2019 · DK · contact PI
Eicosanoid-based Therapy for Diabetes$474,430
R01 · FY2018 · DK · contact PI
Eicosanoid-based Therapy for Diabetes$474,430
R01 · FY2017 · DK · contact PI
Eicosanoid-based Therapy for Diabetes$474,430
R01 · FY2016 · DK · contact PI
Eicosanoid-based Therapy for Diabetes$485,131
R01 · FY2015 · DK · contact PI
P450 Monooxygenases and Renal Vascular Function$170,670
P01 · FY2013 · DK · contact PI
P450 Monooxygenases and Renal Vascular Function$181,163
P01 · FY2012 · DK · contact PI
Epoxyeicosanoids and Renal Vascular Function in Obesity & Hypertension$380,250
R01 · FY2011 · HL · contact PI
P450 Monooxygenases and Renal Vascular Function$184,870
P01 · FY2011 · DK · contact PI
Epoxyeicosanoids and Renal Vascular Function in Obesity & Hypertension$380,250
R01 · FY2010 · HL · contact PI
P450 Monooxygenases and Renal Vascular Function$193,681
P01 · FY2010 · DK · contact PI
Epoxyeicosanoids and Renal Vascular Function in Obesity & Hypertension$376,185
R01 · FY2009 · HL · contact PI
P450 Monooxygenases and Renal Vascular Function$237,190
P01 · FY2009 · DK · contact PI
Epoxyeicosanoids and Renal Vascular Function in Obesity & Hypertension$76,000
R01 · FY2009 · HL · contact PI
Epoxyeicosanoids and Renal Vascular Function in Obesity & Hypertension$389,060
R01 · FY2008 · HL · contact PI
Renal Endothelial Dysfunction in Salt-Sensitive Hypertension$283,747
P01 · FY2008 · HL · contact PI
Eicosanoids and Renal Microvascular Function$271,752
P01 · FY2008 · DK · contact PI
Renal Endothelial Dysfunction in Salt-Sensitive Hypertension$290,850
P01 · FY2007 · HL · contact PI
Eicosanoids and Renal Microvascular Function$217,898
P01 · FY2007 · DK · contact PI
Eicosanoids and Renal Microvascular Function$241,959
P01 · FY2006 · DK · contact PI
Renal Endothelial Dysfunction in Na-Sensitive Hypertensi$190,962
P01 · FY2006 · HL · contact PI
Oxygenase Metabolites and Renal Microvascular Reactivity$301,125
R01 · FY2005 · HL
Eicosanoids and Renal Microvascular Function$241,958
P01 · FY2005 · DK
Renal Endothelial Dysfunction in Na-Sensitive Hypertensi$185,399
P01 · FY2005 · HL
Novel epoxide hydrolase inhibitor for stroke prevention$100,000
R41 · FY2005 · NS
Oxygenase Metabolites and Renal Microvascular Reactivity$301,125
R01 · FY2004 · HL
Eicosanoids and Renal Microvascular Function$254,706
P01 · FY2004 · DK
Renal Endothelial Dysfunction in Na-Sensitive Hypertensi$180,000
P01 · FY2004 · HL
Oxygenase Metabolites and Renal Microvascular Reactivity$301,125
R01 · FY2003 · HL
Oxygenase Metabolites and Renal Microvascular Reactivity$312,000
R01 · FY2002 · HL
ROLE OF P450 MONOOXYGENASES IN RENAL HEMODYNAMICS$162,614
P01 · FY2002 · DK
ROLE OF P450 MONOOXYGENASES IN RENAL HEMODYNAMICS$162,614
P01 · FY2001 · DK
OXYGENASE METABOLITES AND RENAL VASCULAR ACTIVITY$69,000
R01 · FY2001 · HL
OXYGENASE METABOLITES AND RENAL VASCULAR ACTIVITY$27,519
R01 · FY2001 · HL
ROLE OF P450 MONOOXYGENASES IN RENAL HEMODYNAMICS$162,614
P01 · FY2000 · DK
OXYGENASE METABOLITES AND RENAL VASCULAR ACTIVITY$92,972
R01 · FY2000 · HL